Apatinib Combined with Irinotecan in the Treatment of Advanced Small-Cell Esophageal Carcinoma: A Case Report

Chemotherapy is the mainstay of treatment for advanced small cell esophageal carcinoma (SCEC) characterized by poor prognosis. Preclinical studies demonstrated that apatinib has the potential to enhance the efficacy of conventional chemotherapeutic drugs and reverse multidrug resistance (MDR). This...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Longhua, Zou, Xiaofang, Gu, Yinfang, Yi, Lilan, Zhao, Jingjing, Wu, Guowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987322/
https://www.ncbi.nlm.nih.gov/pubmed/33776448
http://dx.doi.org/10.2147/OTT.S295067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987322/
https://www.ncbi.nlm.nih.gov/pubmed/33776448
http://dx.doi.org/10.2147/OTT.S295067

Ejemplares similares